Comparison between Mangal Compusolution IPO and Onyx Biotec IPO.
IPO Details
Mangal Compusolution IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Onyx Biotec IPO is a SME Bookbuilding proposed to list at NSE SME.
The total issue size of Mangal Compusolution IPO is up to ₹15.39 Cr whereas the issue size of the Onyx Biotec IPO is up to ₹27.85 Cr. The final issue price of Mangal Compusolution IPO is ₹45.00 per share and of Onyx Biotec IPO is ₹61.00 per share.
Mangal Compusolution IPO opens on Nov 12, 2024, while Onyx Biotec IPO opens on Nov 13, 2024. The closing date of Mangal Compusolution IPO and Onyx Biotec IPO is Nov 14, 2024, and Nov 18, 2024, respectively.
In the Mangal Compusolution IPO Retail Individual Investors (RII) are offered 17,10,000 shares while in Onyx Biotec IPO retail investors are offered 17,10,000 shares. Qualified Institutional Buyers (QIB) are offered in Mangal Compusolution IPO and 9,12,000 shares in Onyx Biotec IPO.